Low-dose naltrexone, often called LDN, is one of the most discussed medications in chronic pain, autoimmune, and complex illness communities. Many patients ask about it. Many providers hesitate because it is prescribed off-label.
The reality is that LDN is not a magic bullet, but for the right patient, it can be a useful tool, especially when pain involves both nervous system sensitization and immune dysfunction.
What Low-Dose Naltrexone Is
At standard doses, naltrexone is used for opioid and alcohol use disorders. At much lower doses, usually in the 1 mg to 4.5 mg range, it behaves differently.
LDN is thought to create a brief, temporary blockade of opioid receptors. This may trigger a rebound effect in the body’s own endorphin system, while also influencing immune and inflammatory pathways.
That is why LDN is often considered in patients whose pain is not purely mechanical, but instead involves central sensitization, immune activation, or chronic inflammatory signaling.
Who It May Help
LDN may be considered in patients with complex chronic pain, fibromyalgia-like symptoms, mast cell activation symptoms, autoimmune disease, post-infectious syndromes, endometriosis, chronic pelvic pain, or long-standing nervous system sensitivity.
The common thread is not one diagnosis. It is the pattern: a body that appears stuck in a state of inflammation, reactivity, and amplified pain signaling.
Why Dosing Matters
With LDN, more is not always better. Many patients do best when the dose is slowly increased and adjusted carefully.
Some may feel better at a lower dose and lose benefit if they go too high. Others may need several weeks before noticing the full effect. LDN is not an acute painkiller. It is usually used as a longer-term modulating medication.
Side effects are often related to sleep and adjustment, including vivid dreams, mild nausea, or temporary irritability during titration.
What LDN Does Not Do
LDN does not stabilize a hypermobile joint, repair a torn ligament, fix a herniated disc, or replace a proper mechanical workup.
It may help quiet the inflammatory and nervous system “volume,” but it should not be used as a substitute for identifying what is driving the pain.
Patients using opioids or planning surgery should discuss timing and safety carefully with their prescribing clinician.
Our Approach at MPM
At Manhattan Pain Medicine, we consider LDN as one tool within a broader diagnosis-first plan, helping patients understand whether their pain is mechanical, inflammatory, nervous-system driven, or layered.
